A mix of domestic revenue generation, efficiency gains and strategic partnerships is essential to sustain and expand HIV ...

Lenacapavir, a long-acting injectable form of HIV prevention, is set to revolutionise HIV prevention strategies in South ...

Gilead Sciences’ pre-exposure prophylaxis (PrEP) formula of lenacapavir has been approved in the UK as a preventative option ...

A daily preventive pill can be invaluable for people at risk for HIV. But some doctors don't know much about prescribing them. And billing headaches are common. Here's how to overcome those hurdles.

The U.S. Food and Drug Administration (FDA) recently approved a groundbreaking new option for preventing HIV, the virus that causes AIDS. The injectable drug lenacapavir was approved in June and is ...

A study suggests twice-yearly Yeztugo offers HIV prevention without adversely affecting gender-affirming care.

Key PointsResearch on HIV's conical capsid that began over 25 years ago led to the development of lenacapavir, the world's first capsid inhibitor.In ...

WHO’s 2025 HIV clinical guidelines simplify and strengthen care by recommending more durable, safer treatment regimens, ...

Frank Gupton, CEO of Medicines for All, said he hopes that will lead to production facilities closer to those high need areas like sub-Saharan Africa.

In the region, the definition of “high-risk drug use”/“problem drug use” is limited to “current injecting drug use” due to ...

Knowable Magazine reports 2025 faced turmoil in U.S. science amid job cuts and budget slashes, yet saw advances in gene ...